Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 26 | 2025 | 1021 | 4.220 |
Why?
|
| Heart Failure | 29 | 2025 | 2283 | 3.120 |
Why?
|
| Heart Transplantation | 21 | 2024 | 855 | 2.930 |
Why?
|
| Cardiomyopathies | 6 | 2023 | 492 | 1.230 |
Why?
|
| Ventricular Function, Left | 7 | 2022 | 506 | 1.090 |
Why?
|
| Heart Defects, Congenital | 10 | 2025 | 1813 | 1.040 |
Why?
|
| Pericarditis | 2 | 2023 | 42 | 0.800 |
Why?
|
| Child | 44 | 2025 | 24374 | 0.710 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2018 | 19 | 0.620 |
Why?
|
| Overweight | 1 | 2021 | 363 | 0.620 |
Why?
|
| Heart Valve Diseases | 2 | 2021 | 169 | 0.610 |
Why?
|
| Antineoplastic Agents | 3 | 2022 | 1660 | 0.570 |
Why?
|
| Myocarditis | 1 | 2019 | 130 | 0.560 |
Why?
|
| Retrospective Studies | 31 | 2024 | 16317 | 0.540 |
Why?
|
| Fontan Procedure | 1 | 2018 | 182 | 0.510 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2015 | 21 | 0.490 |
Why?
|
| Mitral Valve | 2 | 2018 | 248 | 0.460 |
Why?
|
| Prosthesis Failure | 1 | 2015 | 158 | 0.460 |
Why?
|
| Cardiac Catheterization | 4 | 2023 | 632 | 0.420 |
Why?
|
| Registries | 5 | 2025 | 1424 | 0.410 |
Why?
|
| Humans | 55 | 2025 | 124618 | 0.400 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2018 | 436 | 0.380 |
Why?
|
| Treatment Outcome | 19 | 2024 | 12324 | 0.370 |
Why?
|
| Heart Failure, Systolic | 2 | 2021 | 32 | 0.330 |
Why?
|
| Cardiomyopathy, Dilated | 3 | 2023 | 212 | 0.310 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2022 | 365 | 0.300 |
Why?
|
| Anemia, Iron-Deficiency | 2 | 2021 | 135 | 0.290 |
Why?
|
| Child, Preschool | 18 | 2025 | 14009 | 0.290 |
Why?
|
| Adolescent | 21 | 2025 | 19278 | 0.290 |
Why?
|
| Prosthesis Implantation | 2 | 2019 | 141 | 0.290 |
Why?
|
| Heart Atria | 2 | 2020 | 316 | 0.290 |
Why?
|
| Cancer Survivors | 2 | 2020 | 202 | 0.280 |
Why?
|
| Patient Selection | 2 | 2021 | 693 | 0.270 |
Why?
|
| Neoplasms | 4 | 2022 | 2772 | 0.250 |
Why?
|
| Prosthesis Design | 5 | 2024 | 675 | 0.240 |
Why?
|
| Shock, Cardiogenic | 2 | 2024 | 192 | 0.240 |
Why?
|
| Heart Diseases | 2 | 2020 | 490 | 0.230 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2024 | 37 | 0.230 |
Why?
|
| Urethra | 1 | 2024 | 84 | 0.220 |
Why?
|
| Male | 28 | 2025 | 61200 | 0.220 |
Why?
|
| Cohort Studies | 6 | 2021 | 4795 | 0.210 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 2 | 2022 | 32 | 0.210 |
Why?
|
| Pericardial Effusion | 1 | 2023 | 66 | 0.200 |
Why?
|
| Glomerular Filtration Rate | 3 | 2021 | 503 | 0.190 |
Why?
|
| Graft Rejection | 3 | 2023 | 590 | 0.190 |
Why?
|
| Stroke Volume | 2 | 2022 | 487 | 0.190 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2022 | 77 | 0.190 |
Why?
|
| Thinness | 1 | 2021 | 70 | 0.180 |
Why?
|
| Feasibility Studies | 1 | 2024 | 757 | 0.180 |
Why?
|
| Cardiac Rehabilitation | 1 | 2021 | 24 | 0.180 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2022 | 62 | 0.180 |
Why?
|
| Transplant Recipients | 2 | 2020 | 216 | 0.180 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 457 | 0.180 |
Why?
|
| Adult | 13 | 2024 | 29440 | 0.180 |
Why?
|
| Connectin | 1 | 2020 | 27 | 0.180 |
Why?
|
| Atrial Function, Left | 1 | 2020 | 27 | 0.170 |
Why?
|
| Anthracyclines | 1 | 2020 | 36 | 0.170 |
Why?
|
| Echocardiography | 3 | 2020 | 1052 | 0.170 |
Why?
|
| Female | 25 | 2025 | 66495 | 0.170 |
Why?
|
| Infant | 11 | 2025 | 12468 | 0.170 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2020 | 50 | 0.170 |
Why?
|
| Device Removal | 2 | 2018 | 221 | 0.170 |
Why?
|
| Echocardiography, Doppler | 1 | 2020 | 171 | 0.160 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2020 | 126 | 0.160 |
Why?
|
| Diastole | 1 | 2020 | 170 | 0.160 |
Why?
|
| Pulsatile Flow | 1 | 2019 | 127 | 0.160 |
Why?
|
| Time Factors | 7 | 2025 | 6293 | 0.160 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2019 | 18 | 0.160 |
Why?
|
| American Heart Association | 1 | 2021 | 322 | 0.160 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2019 | 74 | 0.160 |
Why?
|
| Radiation Injuries | 1 | 2020 | 143 | 0.160 |
Why?
|
| Ventricular Function, Right | 1 | 2019 | 110 | 0.150 |
Why?
|
| Young Adult | 9 | 2024 | 9014 | 0.150 |
Why?
|
| Acute Disease | 2 | 2019 | 1110 | 0.150 |
Why?
|
| Central Venous Pressure | 1 | 2018 | 25 | 0.150 |
Why?
|
| Smoking | 1 | 2024 | 1045 | 0.150 |
Why?
|
| Cardiotonic Agents | 1 | 2019 | 138 | 0.150 |
Why?
|
| Vasodilator Agents | 1 | 2019 | 204 | 0.150 |
Why?
|
| Tracheostomy | 1 | 2020 | 192 | 0.150 |
Why?
|
| Forecasting | 1 | 2019 | 351 | 0.150 |
Why?
|
| Amino Acids | 1 | 2020 | 664 | 0.150 |
Why?
|
| Hemodynamics | 1 | 2022 | 848 | 0.140 |
Why?
|
| Arterial Switch Operation | 1 | 2018 | 22 | 0.140 |
Why?
|
| Patient Readmission | 1 | 2021 | 384 | 0.140 |
Why?
|
| Consensus | 1 | 2021 | 646 | 0.140 |
Why?
|
| Hospitals, Pediatric | 2 | 2021 | 770 | 0.140 |
Why?
|
| Immunity, Humoral | 1 | 2018 | 70 | 0.140 |
Why?
|
| Thrombosis | 1 | 2022 | 519 | 0.140 |
Why?
|
| Patient Discharge | 1 | 2021 | 489 | 0.140 |
Why?
|
| Transposition of Great Vessels | 1 | 2018 | 130 | 0.130 |
Why?
|
| Creatinine | 1 | 2018 | 390 | 0.130 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2018 | 159 | 0.130 |
Why?
|
| Pulmonary Artery | 1 | 2019 | 441 | 0.130 |
Why?
|
| Risk Factors | 8 | 2024 | 10270 | 0.130 |
Why?
|
| Kidney Transplantation | 1 | 2021 | 643 | 0.130 |
Why?
|
| Renal Insufficiency | 1 | 2018 | 236 | 0.130 |
Why?
|
| Palliative Care | 1 | 2019 | 427 | 0.120 |
Why?
|
| Body Mass Index | 1 | 2021 | 1561 | 0.120 |
Why?
|
| Stroke | 1 | 2023 | 984 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2023 | 2045 | 0.120 |
Why?
|
| Predictive Value of Tests | 4 | 2022 | 2154 | 0.120 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2015 | 111 | 0.120 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2015 | 239 | 0.110 |
Why?
|
| Follow-Up Studies | 5 | 2025 | 5145 | 0.110 |
Why?
|
| Heart Ventricles | 1 | 2018 | 762 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 1 | 2021 | 879 | 0.110 |
Why?
|
| Electrocardiography | 1 | 2019 | 971 | 0.110 |
Why?
|
| Heart Arrest | 1 | 2017 | 351 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1882 | 0.100 |
Why?
|
| Liver Transplantation | 1 | 2021 | 1038 | 0.100 |
Why?
|
| Miniaturization | 2 | 2024 | 26 | 0.100 |
Why?
|
| Hospital Mortality | 3 | 2024 | 1021 | 0.100 |
Why?
|
| Signal Transduction | 1 | 2023 | 4505 | 0.090 |
Why?
|
| Postoperative Complications | 2 | 2024 | 3065 | 0.090 |
Why?
|
| Obesity | 1 | 2021 | 2262 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2019 | 3445 | 0.080 |
Why?
|
| Hospitalization | 3 | 2024 | 1777 | 0.080 |
Why?
|
| Cardiotoxicity | 2 | 2020 | 33 | 0.080 |
Why?
|
| Graft Survival | 2 | 2021 | 536 | 0.080 |
Why?
|
| Ureteroscopes | 1 | 2008 | 1 | 0.080 |
Why?
|
| Infant, Newborn | 4 | 2023 | 8191 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2021 | 1032 | 0.070 |
Why?
|
| Incidence | 3 | 2018 | 3138 | 0.060 |
Why?
|
| United States | 4 | 2024 | 10891 | 0.060 |
Why?
|
| Survival Rate | 2 | 2021 | 2044 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 1428 | 0.060 |
Why?
|
| Urethral Stricture | 1 | 2024 | 13 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2024 | 6135 | 0.050 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2023 | 43 | 0.050 |
Why?
|
| Length of Stay | 2 | 2019 | 1310 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 1 | 2023 | 124 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2020 | 3281 | 0.050 |
Why?
|
| Age Factors | 2 | 2020 | 2818 | 0.050 |
Why?
|
| Chlorides | 1 | 2022 | 106 | 0.050 |
Why?
|
| Hirudins | 1 | 2022 | 37 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 87 | 0.050 |
Why?
|
| Antithrombins | 1 | 2022 | 56 | 0.050 |
Why?
|
| Chest Pain | 1 | 2023 | 126 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 275 | 0.050 |
Why?
|
| Transferrin | 1 | 2021 | 49 | 0.050 |
Why?
|
| Middle Aged | 4 | 2024 | 26714 | 0.050 |
Why?
|
| Surgical Wound Infection | 1 | 2024 | 260 | 0.050 |
Why?
|
| Diuretics | 1 | 2022 | 171 | 0.050 |
Why?
|
| Sodium | 1 | 2022 | 295 | 0.050 |
Why?
|
| Hemolysis | 1 | 2021 | 112 | 0.050 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2022 | 223 | 0.050 |
Why?
|
| Outpatients | 1 | 2022 | 251 | 0.040 |
Why?
|
| North America | 1 | 2021 | 240 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2020 | 41 | 0.040 |
Why?
|
| Heparin | 1 | 2022 | 227 | 0.040 |
Why?
|
| Exercise Test | 1 | 2021 | 252 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 224 | 0.040 |
Why?
|
| Prognosis | 2 | 2019 | 4625 | 0.040 |
Why?
|
| Systole | 1 | 2020 | 198 | 0.040 |
Why?
|
| Biopsy | 1 | 2023 | 1237 | 0.040 |
Why?
|
| Radiotherapy | 1 | 2020 | 133 | 0.040 |
Why?
|
| Plakophilins | 1 | 2019 | 3 | 0.040 |
Why?
|
| Desmoglein 2 | 1 | 2019 | 3 | 0.040 |
Why?
|
| Observer Variation | 1 | 2020 | 299 | 0.040 |
Why?
|
| Probability | 1 | 2019 | 323 | 0.040 |
Why?
|
| Iron | 1 | 2021 | 267 | 0.040 |
Why?
|
| Bilirubin | 1 | 2019 | 123 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2022 | 460 | 0.040 |
Why?
|
| Myocytes, Cardiac | 1 | 2023 | 603 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 1322 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2022 | 468 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2022 | 1390 | 0.040 |
Why?
|
| Unnecessary Procedures | 1 | 2019 | 59 | 0.040 |
Why?
|
| Myocardium | 1 | 2023 | 997 | 0.040 |
Why?
|
| Aortic Valve | 1 | 2021 | 441 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2020 | 348 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2021 | 495 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2024 | 639 | 0.040 |
Why?
|
| Incidental Findings | 1 | 2019 | 125 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2022 | 779 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2020 | 473 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2020 | 442 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 721 | 0.040 |
Why?
|
| Exons | 1 | 2020 | 796 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2023 | 3040 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 236 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2022 | 589 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2019 | 722 | 0.030 |
Why?
|
| Heart | 1 | 2022 | 708 | 0.030 |
Why?
|
| Apoptosis | 1 | 2023 | 1789 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1089 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2019 | 460 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2023 | 2287 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2019 | 445 | 0.030 |
Why?
|
| Logistic Models | 1 | 2021 | 1805 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2018 | 443 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2018 | 662 | 0.030 |
Why?
|
| Oxygen | 1 | 2019 | 553 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2020 | 542 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 1350 | 0.030 |
Why?
|
| Pacemaker, Artificial | 1 | 2017 | 174 | 0.030 |
Why?
|
| Pandemics | 1 | 2023 | 1099 | 0.030 |
Why?
|
| Reoperation | 1 | 2018 | 832 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2021 | 852 | 0.030 |
Why?
|
| Recurrence | 1 | 2018 | 1420 | 0.030 |
Why?
|
| Alleles | 1 | 2019 | 1615 | 0.030 |
Why?
|
| Exome | 1 | 2019 | 1034 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 2876 | 0.030 |
Why?
|
| Global Health | 1 | 2017 | 560 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 1179 | 0.030 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2019 | 627 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2019 | 1001 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2019 | 1497 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2019 | 723 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 3424 | 0.020 |
Why?
|
| Quality of Life | 1 | 2021 | 1916 | 0.020 |
Why?
|
| Texas | 1 | 2018 | 3584 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 3153 | 0.020 |
Why?
|
| Mice | 1 | 2023 | 17639 | 0.020 |
Why?
|
| Equipment Design | 1 | 2008 | 598 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 19703 | 0.020 |
Why?
|
| Mutation | 1 | 2019 | 5826 | 0.020 |
Why?
|
| Animals | 1 | 2023 | 34088 | 0.010 |
Why?
|